<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01504633</url>
  </required_header>
  <id_info>
    <org_study_id>NUPICO-Indonesia</org_study_id>
    <nct_id>NCT01504633</nct_id>
  </id_info>
  <brief_title>Nutrigenomics, PUFA, Iron and Cognition Amongst Under-two-year-old Indonesian Children</brief_title>
  <acronym>NUPICO</acronym>
  <official_title>Can NUtrigenomics / Nutrigenetics Help Explain the Mixed Results on Effect of LCPUFA (DHA) and Iron on Child COgnition?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Review on the positive effect of long chain polyunsaturated fatty acids (LCPUFA),
      especially docosahexanoic acid (DHA), supplementation on cognitive function in human using
      randomized controlled trials (RCTs) showed that results in RCTs were mixed and inconsistent.
      It has been suggested that the effect may be subtle, which is currently difficult to detect,
      but could be significant, or there may be individual variation which mediate the effect.

      Objectives: This study aims to assess gene-nutrient inter-relation in explaining the effect
      of LCPUFAs i.e. DHA and/or iron on cognitive functioning of children &lt;24mo in Indonesia.
      Specifically the study's objectives are: (1) to assess effect of LCPUFA (as DHA oil) and iron
      (as iron supplement) in altering gene expressions, and (2) to assess the mediating effect of
      genes involved in fatty acid and iron metabolism in improving serum LCPUFA, alpha-linolenic
      acids (ALA), DHA and cognitive function.

      Study design and study population: The study is a double-blind randomized controlled trial
      with children aged less than 24 months (window of opportunity). The study area is in East
      Lombok district, in West Nusa Tenggara province, Indonesia where nutrient intake including
      iron and presumably LCPUFA, is not optimal.

      Intervention: The study is an intervention study, consisting of four groups: DHA, iron,
      DHA+iron, and placebo (60 subjects/group = 240 subjects in total). Capsule containing 100mg/d
      DHA or its placebo and syrup containing 16mg/d iron will be given daily for 24 weeks. Before
      and after the intervention child cognition (as Bayley Mental Developmental Index or MDI
      score), serum PUFA level, iron status (haemoglobin, transferrin receptor, ferritin),
      inflammation status (CRP, AGP), gene expression profiles, and potential confounders of child
      cognition such as lengt-for-age, weight-for-length, and weight-for-age Z-scores,
      stimulation/home environment, maternal characteristics will be collected.

      Study outcome: The primary study outcomes will be cognitive score (as Bayley Mental
      Developmental Index or MDI score) and gene expression profiles. Secondary study outcomes will
      be serum PUFA level, iron status (haemoglobin, TfR, ferritin).

      Nature and extent of the burden and risks benefit and group relatedness:

      Subjects, who will be included into the study will invest 14 hours. The consumption of iron
      is not associated with any increased risk of iron overload both for infectious (including
      malaria) and chronic diseases nor consumption of n-3 fatty acids EPA and DHA exceed the US
      Food and Drug Administrator (FDA) Generally Recognized as Save (GRAS) limit. Venous blood of
      5 mL will be drawn at baseline and endline. During screening, children with severe anaemia
      (Hb&lt;70g/L) will be excluded from the study and referred to the local public health center for
      further treatment.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in cognitive function (MDI score)</measure>
    <time_frame>within 24 weeks after start of intervention</time_frame>
    <description>Mental Developmental Index (MDI) score of Bayley Scale of Infant Development (BSID)</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Cognitive Ability, General</condition>
  <arm_group>
    <arm_group_label>DHA+EPA Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DHA/EPA capsule (100mg DHA + 20mg) and placebo syrup per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fe Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo capsule and Fe syrup (16mg elemental iron) per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DHA/EPA+Fe Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DHA/EPA capsule (100mg DHA + 20mg) and Fe syrup (16mg elemental iron) per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo capsule and placebo syrup</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>DHA/EPA and iron supplementation</intervention_name>
    <description>24-week supplementation consisting of daily dosage of DHA/EPA or placebo capsule and iron/placebo syrup Capsule: DHA/EPA (100mg DHA + 20mg per day) or placebo Syrup: Fe syrup (16mg elemental iron per day) or placebo</description>
    <arm_group_label>DHA+EPA Group</arm_group_label>
    <arm_group_label>Fe Group</arm_group_label>
    <arm_group_label>DHA/EPA+Fe Group</arm_group_label>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Child aged 12 to 17months old

          -  Both father and mother of Sasak ethnicity

          -  Currently breastfed

        Exclusion Criteria:

          -  Birth weight &lt;2500 grams (LBW)

          -  Congenital malformation and/or disorder that interfered with adequate functioning in
             daily life

          -  Hemoglobin value below 70 g/L

          -  Malaria

          -  Maternal depression
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>16 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Umi Fahmida, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SEAMEO Regional Center for Food and Nutrition (RECFON) University of Indonesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SEAMEO Regional Center for Food and Nutrition (RECFON) University of Indonesia</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <link>
    <url>http://seameo-recfon.org/</url>
    <description>South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition, University of Indonesia</description>
  </link>
  <reference>
    <citation>Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1467S-1476S. doi: 10.1093/ajcn/83.6.1467S. Review.</citation>
    <PMID>16841856</PMID>
  </reference>
  <reference>
    <citation>Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, Geleijnse JM, Müller M, Afman LA. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr. 2009 Aug;90(2):415-24. doi: 10.3945/ajcn.2009.27680. Epub 2009 Jun 10.</citation>
    <PMID>19515734</PMID>
  </reference>
  <reference>
    <citation>Bouwens M, Grootte Bromhaar M, Jansen J, Müller M, Afman LA. Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles. Am J Clin Nutr. 2010 Jan;91(1):208-17. doi: 10.3945/ajcn.2009.28586. Epub 2009 Nov 18.</citation>
    <PMID>19923369</PMID>
  </reference>
  <reference>
    <citation>Cunnane SC, McAdoo KR. Iron intake influences essential fatty acid and lipid composition of rat plasma and erythrocytes. J Nutr. 1987 Sep;117(9):1514-9.</citation>
    <PMID>3116180</PMID>
  </reference>
  <reference>
    <citation>El-khayat H, Shaaban S, Emam EK, Elwakkad A. Cognitive functions in protein-energy malnutrition: in relation to long chain-polyunsaturated fatty acids. Pak J Biol Sci. 2007 Jun 1;10(11):1773-81.</citation>
    <PMID>19086537</PMID>
  </reference>
  <reference>
    <citation>Idjradinata P, Pollitt E. Reversal of developmental delays in iron-deficient anaemic infants treated with iron. Lancet. 1993 Jan 2;341(8836):1-4.</citation>
    <PMID>7678046</PMID>
  </reference>
  <reference>
    <citation>Koletzko B, Demmelmair H, Schaeffer L, Illig T, Heinrich J. Genetically determined variation in polyunsaturated fatty acid metabolism may result in different dietary requirements. Nestle Nutr Workshop Ser Pediatr Program. 2008;62:35-44; discussion 44-9. doi: 10.1159/000146246. Review.</citation>
    <PMID>18626191</PMID>
  </reference>
  <reference>
    <citation>Kwik-Uribe CL, Gietzen D, German JB, Golub MS, Keen CL. Chronic marginal iron intakes during early development in mice result in persistent changes in dopamine metabolism and myelin composition. J Nutr. 2000 Nov;130(11):2821-30.</citation>
    <PMID>11053527</PMID>
  </reference>
  <reference>
    <citation>McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr. 2005 Aug;82(2):281-95. Review.</citation>
    <PMID>16087970</PMID>
  </reference>
  <reference>
    <citation>McCann JC, Ames BN. An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am J Clin Nutr. 2007 Apr;85(4):931-45. Review.</citation>
    <PMID>17413089</PMID>
  </reference>
  <reference>
    <citation>Murray-Kolb LE, Beard JL. Iron deficiency and child and maternal health. Am J Clin Nutr. 2009 Mar;89(3):946S-950S. doi: 10.3945/ajcn.2008.26692D. Epub 2009 Jan 21.</citation>
    <PMID>19158210</PMID>
  </reference>
  <reference>
    <citation>Oloyede OB, Folayan AT, Odutuga AA. Effects of low-iron status and deficiency of essential fatty acids on some biochemical constituents of rat brain. Biochem Int. 1992 Aug;27(5):913-22.</citation>
    <PMID>1417923</PMID>
  </reference>
  <reference>
    <citation>Smuts CM, Tichelaar HY, van Jaarsveld PJ, Badenhorst CJ, Kruger M, Laubscher R, Mansvelt EP, Benadé AJ. The effect of iron fortification on the fatty acid composition of plasma and erythrocyte membranes in primary school children with and without iron deficiency. Prostaglandins Leukot Essent Fatty Acids. 1995 Jan;52(1):59-67.</citation>
    <PMID>7708822</PMID>
  </reference>
  <reference>
    <citation>Stangl GI, Kirchgessner M. Different degrees of moderate iron deficiency modulate lipid metabolism of rats. Lipids. 1998 Sep;33(9):889-95.</citation>
    <PMID>9778136</PMID>
  </reference>
  <reference>
    <citation>Rajilić-Stojanović M, Heilig HG, Molenaar D, Kajander K, Surakka A, Smidt H, de Vos WM. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol. 2009 Jul;11(7):1736-51. doi: 10.1111/j.1462-2920.2009.01900.x. Epub 2009 Mar 11.</citation>
    <PMID>19508560</PMID>
  </reference>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 31, 2011</study_first_submitted>
  <study_first_submitted_qc>January 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2012</study_first_posted>
  <last_update_submitted>February 25, 2014</last_update_submitted>
  <last_update_submitted_qc>February 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Umi Fahmida</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>cognitive function</keyword>
  <keyword>omega-3 PUFA (DHA)</keyword>
  <keyword>iron</keyword>
  <keyword>nutrigenomics</keyword>
  <keyword>under-two year old children</keyword>
  <keyword>Indonesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

